5777 W. Century Blvd. Suite 360

Los Angeles, CA 90045

310-258-5000

COMPUMED ANNOUNCES SHAREHOLDER PURCHASE AND RENEWED AGREEMENT WITH CEO

LOS ANGELES, CA (January 15, 2015) - CompuMed, Inc. (OTCPink: CMPD), the leaders in providing enterprise telemedicine solutions, announced today that the VI Capital Fund, LP has purchased all of the CompuMed, Inc. share holdings of Boston Avenue Capital and Yorktown Avenue Capital. In addition to purchasing the common stock owned by both Yorktown Avenue Capital and Boston Avenue Capital, VI Capital Fund, LP has also purchased the Series D Preferred shares formerly held by Boston Avenue Capital as well as the line-of-credit held by Boston Avenue Capital.

VI Capital Fund, LP is a Washington State Limited Partnership. The Fund is managed by its General Partner VI Capital Management, LLC. VI Capital Management, LLC is a single member LLC owned by Mr. David Pointer. Mr. Pointer has served on CompuMed, Inc.'s Board of Directors since December of 2013, and became CompuMed, Inc.'s Chairman of the Board in October 2014.

Additionally, CompuMed, Inc.'s Board of Directors are pleased to announce an ongoing employment agreement between

the Company and CEO W. Scott Rombach.

Scott Rombach, CompuMed, Inc.'s CEO commented: "We appreciate the confidence Dave has expressed in the future of

CompuMed, and we are excited to be entering this new era for our company."

About CompuMed, Inc.

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at
reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud- based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over
26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com
.

Forward-Looking Statements

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are
forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of a ppropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc. Investor Relations: investorrelations@compumedinc.com (310) 258-5000 x117

distributed by